Osaic Holdings’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$777 Hold
306
– – ﹤0.01% 7611
2026
Q2
$823 Buy
+306
New +$790 ﹤0.01% 7538
2025
Q4
– Sell
-5
Closed -$6 – 8071
2025
Q3
$6 Hold
5
– – ﹤0.01% 7874
2025
Q2
$1 Hold
5
– – ﹤0.01% 7731
2025
Q1
$1 Sell
5
-285
-98% -$175 ﹤0.01% 7416
2024
Q4
$271 Sell
290
-140
-33% -$157 ﹤0.01% 7130
2024
Q3
$507 Hold
430
– – ﹤0.01% 7010
2024
Q2
$331 Sell
430
-16
-4% -$45 ﹤0.01% 7085
2024
Q1
$1.36K Buy
446
+140
+46% +$468 ﹤0.01% 6604
2023
Q4
$985 Hold
306
– – ﹤0.01% 6765
2023
Q3
$1.18K Hold
306
– – ﹤0.01% 6784
2023
Q2
$1K Sell
306
-25
-8% -$85 ﹤0.01% 6880
2023
Q1
$854 Hold
331
– – ﹤0.01% 7008
2022
Q4
$1K Hold
331
– – ﹤0.01% 6920
2022
Q3
$1K Hold
331
– – ﹤0.01% 7031
2022
Q2
$1K Hold
331
– – ﹤0.01% 7126
2022
Q1
$1K Hold
331
– – ﹤0.01% 7093
2021
Q4
$1K Sell
331
-100
-23% -$343 ﹤0.01% 7225
2021
Q3
$1K Buy
431
+25
+6% +$91 ﹤0.01% 7054
2021
Q2
$1K Sell
406
-100
-20% -$395 ﹤0.01% 6872
2021
Q1
$2K Hold
506
– – ﹤0.01% 6507
2020
Q4
$1K Sell
506
-25
-5% -$117 ﹤0.01% 6248
2020
Q3
$3K Sell
531
-300
-36% -$2.01K ﹤0.01% 5747
2020
Q2
$6K Buy
+831
New +$3.89K ﹤0.01% 5411

Other funds holding OVID

Osaic Holdings's OVID Position: Q3 2026 in Review

Osaic Holdings held its Ovid Therapeutics (OVID) position steady in Q3 2026 at 306 shares worth $777. The position accounts for ﹤0.01% of the portfolio, ranked #7611.

Osaic Holdings first reported a position in OVID in Q2 2020 and has held it in 24 quarters since. The position peaked at $6K in Q2 2020. 129 funds tracked by Wall St. Rank hold OVID as of Q3 2026.

  • Osaic Holdings held 306 shares of Ovid Therapeutics worth $777 as of Q3 2026.
  • Osaic Holdings left its Ovid Therapeutics share count unchanged in Q3 2026.
  • Ovid Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7611 holding.
  • Osaic Holdings first reported a position in Ovid Therapeutics in Q2 2020 and has held it in 24 quarters since.
  • Osaic Holdings's Ovid Therapeutics position peaked at $6K in Q2 2020.
  • 129 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.